English
Italiano
Log In(current)
Repository logoRepository logo
Who We Are✱Collections✱News and Events✱Contacts
  1. Home
  2. PUBBLICAZIONE/PUBLICATION
  3. Journal Article
  4. Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors
  • Details

Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors

Publication type
journal article
Publication date
2020
Author(s)
Whitelaw, Sera
Thabane, Lehana
Mamas, Mamas A.
Reza, Nosheen
Breathett, Khadijah
more
Language
English
Keywords

Female

Humans

Authorship

Bibliometrics

Periodicals as Topic

Publishing

Heart Failure

Randomized Controlled...

Gender

Authors

Randomized Controlled...

View point(s)
Global
Discipline(s)

Cardiology

Abstract
BACKGROUND: Clinical trials change practice in cardiology, and leading them requires research training, mentorship, sponsorship, and networking. Women report challenges in obtaining these opportunities. OBJECTIVES: The purpose of this review was to evaluate temporal trends in representation of women as authors in heart failure (HF) randomized controlled trials (RCTs) published in high-impact medical journals and explore RCT characteristics associated with women as lead authors. METHODS: We searched MEDLINE, EMBASE, and CINAHL for HF RCTs published in journals with an impact factor ≥10 between January 1, 2000, and May 7, 2019. We assessed temporal trends in the gender distribution of authors, and used multivariable logistic regression to determine characteristics associated with women as lead authors. RESULTS: We identified 10,596 unique articles, of which 403 RCTs met inclusion criteria. Women represented 15.6% (95% confidence interval [CI]: 12.2% to 19.6%), 12.9% (95% CI: 9.8% to 16.6%), and 11.4% (95% CI: 8.5% to 14.9%) of lead, senior, and corresponding authors, respectively. The proportion of women authors has not changed over time. Women had lower odds of lead authorship in RCTs that were multicenter (odds ratio [OR]: 0.58; 95% CI: 0.18 to 0.96; p = 0.037), were coordinated in North America (OR: 0.21; 95% CI: 0.08 to 0.70; p = 0.011) or Europe (OR: 0.33; 95% CI: 0.09 to 0.91; p = 0.039), tested drug interventions (OR: 0.42; 95% CI: 0.16 to 0.97; p = 0.043), or had men as the senior author (OR: 0.50; 95% CI: 0.21 to 0.93; p = 0.043). CONCLUSIONS: Women are under-represented as authors of HF RCTs, with no change in temporal trends. Women had lower odds of lead authorship in RCTs that were multicenter, were coordinated in North America or Europe, tested drug interventions, or had men as senior authors.
Journal
Journal of the American College of Cardiology
ISSN
1558-3597
DOI
10.1016/j.jacc.2020.08.062
Volume
76
Issue
17
Pagination
1919-1930
https://libkey.io/libraries/2561/articles/417721159/full-text-file?utm_source=api_2667&allow_speedbump=true
Repository logo
Sistema Bibliotecariodi Ateneo SBA
gendermore@unimore.it
www.sba.unimore.it
Privacy policy
End User Agreement
Send Feedback

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Accessibility settings
Repository logo COAR Notify